BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37854674)

  • 1. Microenvironmental immune cell alterations across the spectrum of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
    Panayi C; Akarca AU; Ramsay AD; Shankar AG; Falini B; Piris MA; Linch D; Marafioti T
    Front Oncol; 2023; 13():1267604. PubMed ID: 37854674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spatial phenotyping of nodular lymphocyte predominant Hodgkin lymphoma and T-cell/histiocyte-rich large B-cell lymphoma.
    Younes S; Subramanian A; Khan A; Zhao S; Binkley M; Natkunam Y
    Blood Cancer J; 2024 May; 14(1):92. PubMed ID: 38821935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Array comparative genomic hybridization reveals similarities between nodular lymphocyte predominant Hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma.
    Hartmann S; Döring C; Vucic E; Chan FC; Ennishi D; Tousseyn T; de Wolf-Peeters C; Perner S; Wlodarska I; Steidl C; Gascoyne RD; Hansmann ML
    Br J Haematol; 2015 May; 169(3):415-22. PubMed ID: 25644177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular lymphocyte predominant hodgkin lymphoma and T cell/histiocyte rich large B cell lymphoma--endpoints of a spectrum of one disease?
    Hartmann S; Döring C; Jakobus C; Rengstl B; Newrzela S; Tousseyn T; Sagaert X; Ponzoni M; Facchetti F; de Wolf-Peeters C; Steidl C; Gascoyne R; Küppers R; Hansmann ML
    PLoS One; 2013; 8(11):e78812. PubMed ID: 24244368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma.
    Boudová L; Torlakovic E; Delabie J; Reimer P; Pfistner B; Wiedenmann S; Diehl V; Müller-Hermelink HK; Rüdiger T
    Blood; 2003 Nov; 102(10):3753-8. PubMed ID: 12881319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical variants of nodular lymphocyte-predominant Hodgkin lymphoma show low microvessel density and vessels of distention type.
    Scheidt V; Hansmann ML; Schuhmacher B; Döring C; Hartmann S
    Hum Pathol; 2017 Feb; 60():129-136. PubMed ID: 27816718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma.
    Kosari F; Bakhshi T; Ameli F; Mokhtari M
    BMC Cancer; 2022 Dec; 22(1):1359. PubMed ID: 36577979
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophages in T cell/histiocyte rich large B cell lymphoma strongly express metal-binding proteins and show a bi-activated phenotype.
    Hartmann S; Tousseyn T; Döring C; Flüchter P; Hackstein H; Herreman A; Ponzoni M; de Wolf-Peeters C; Facchetti F; Gascoyne RD; Küppers R; Steidl C; Hansmann ML
    Int J Cancer; 2013 Dec; 133(11):2609-18. PubMed ID: 23686423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reactive T cells by flow cytometry distinguish Hodgkin lymphomas from T cell/histiocyte-rich large B cell lymphoma.
    Wu D; Thomas A; Fromm JR
    Cytometry B Clin Cytom; 2016 Sep; 90(5):424-32. PubMed ID: 26084540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow Cytometric Detection of the Double-Positive (CD4+CD8+)/PD-1bright T-Cell Subset Is Useful in Diagnosing Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
    Chen ZW; Wizniak J; Shang C; Lai R
    Arch Pathol Lab Med; 2022 Jun; 146(6):718-726. PubMed ID: 34506624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The spectrum of nodular lymphocyte predominant Hodgkin lymphoma: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Hartmann S; Dojcinov S; Dotlic S; Gibson SE; Hsi ED; Klapper W; Klimkowska M; Pinilla SMR; Richter J; Sabattini E; Tousseyn T; de Jong D
    Virchows Arch; 2023 Oct; 483(4):451-463. PubMed ID: 37530790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nodular lymphocyte predominant Hodgkin lymphoma: pathology, clinical course and relation to T-cell/histiocyte rich large B-cell lymphoma.
    Hartmann S; Eichenauer DA
    Pathology; 2020 Jan; 52(1):142-153. PubMed ID: 31785822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestinal presentation of nodular lymphocyte-predominant Hodgkin lymphoma with T cell/histiocyte-rich B cell lymphoma-like areas-with review of literature on extranodal presentation of this disease.
    Bagwan IN; Knee G; Abboudi Z; Naresh KN
    J Hematop; 2010 Mar; 3(1):29-34. PubMed ID: 21436871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma].
    Liu YH; Zhuang HG; Lin HL; Wu QL; Luo DL; Li L; Luo XL
    Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):594-8. PubMed ID: 17243292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Large B-cell lymphoma with T-cell-rich background and nodules lacking follicular dendritic cell meshworks: description of an insufficiently recognized variant.
    Treetipsatit J; Metcalf RA; Warnke RA; Natkunam Y
    Hum Pathol; 2015 Jan; 46(1):74-83. PubMed ID: 25456392
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pitfalls in the Diagnosis of Nodular Lymphocyte Predominant Hodgkin Lymphoma: Variant Patterns, Borderlines and Mimics.
    Younes S; Rojansky RB; Menke JR; Gratzinger D; Natkunam Y
    Cancers (Basel); 2021 Jun; 13(12):. PubMed ID: 34208705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 3D analyses reveal T cells with activated nuclear features in T-cell/histiocyte-rich large B-cell lymphoma.
    Sadeghi Shoreh Deli A; Scharf S; Steiner Y; Bein J; Hansmann ML; Hartmann S
    Mod Pathol; 2022 Oct; 35(10):1431-1438. PubMed ID: 35173297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nodular Lymphocyte Predominant Hodgkin Lymphoma versus T-Cell/Histiocyte-Rich Large B-Cell Lymphoma: A Diagnostic Challenge.
    Rets AV; Gottesman SR
    Case Rep Pathol; 2014; 2014():956217. PubMed ID: 25110597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Case of Chemotherapy-Refractory "THRLBCL like Transformation of NLPHL" Successfully Treated with Lenalidomide.
    Siricilla M; Irwin L; Ferber A
    Case Rep Oncol Med; 2018; 2018():6137454. PubMed ID: 29552367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does functional imaging distinguish nodular lymphocyte-predominant hodgkin lymphoma from T-cell/histiocyte-rich large B-cell lymphoma?
    Barber NA; Loberiza FR; Perry AM; Bast M; Holdeman KP; Esfahane AB; Weisenburger DD; Vose J; Bierman P; Armitage JO; Bociek RG
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):392-7. PubMed ID: 23773450
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.